期刊文献+

葡萄糖激酶基因突变与功能学研究进展 被引量:3

Mutations of glucokinase gene and the progress in studies on its functional analysis
下载PDF
导出
摘要 葡萄糖激酶(GCK)基因突变包括激活突变和失活突变,激活突变引起持续性高胰岛素血症低血糖(PHH I),完全性失活突变引起永久性新生儿糖尿病(PNDM),部分性失活突变导致成年起病的青少年糖尿病2型(MODY2)。目前已报道了近200个GCK基因突变,其中只对约1/5的突变进行了功能学研究。本文就GCK基因突变及其目前的功能学研究进展作一综述。 Mutations of glucokinase (GCK) gene include inactive mutation and active mutation. Active mutation induces persistent hyperinsulinemic hypoglycemia of infant (PHHI). Complete inactive mutation induces permanent neonatal diabetes mellitus (PNDM), and partial inactives mutation induces maturity-onset diabetes of the young type 2 (MODY2). About 200 GCK gene mutations have been reported, but functional analysis only have been carried out on one fifth of these mutations. This article reviews the progress in functional analysis on GCK gene mutations.
出处 《国际内科学杂志》 CAS 2008年第12期692-695,共4页 International Journal of Internal Medicine
关键词 葡萄糖激酶 基因突变 功能学研究 Glucokinase Gene mutation Functional analysis
  • 相关文献

参考文献20

  • 1Froguel PH, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature, 1992,356 (6365) : 162-164.
  • 2Matschinsky FM. Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diabetes Rep, 2005,5 (3):171-176.
  • 3Alvarez E, Roncero I, Chowen JA, et al. Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem, 2002 , 80 ( 1 ) : 45- 53.
  • 4Christesen HB, Jacobsen BB, Odili S, et al. The second activating glucokinase mutation (A456V) : implications for glucose homeostasis and diabetes therapy . Diabetes, 2002, 51 (4) :1240-1246.
  • 5Cuesta-Munoz AL, Huopio H, Otonkoski T, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes, 2004, 53 (8) :2164-2168.
  • 6Gloyn AL, Noordam K, Willemsen MA, et al. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes, 2003, 52(9) :2433-2440.
  • 7Njolstad PR, Sovik O, Cuesta-Munoz A, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency . N Engl J Med, 2001, 344(21) :1588-1592.
  • 8Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent neonatal diabetes mellitus caused by glucokinase deficiency:inborn error of the glucose-insulin signaling pathway . Diabetes,2003, 52( 11 ) :2854-2860.
  • 9Liang Y, Kesavan P, Wang LQ, et al. Variable effects of maturity-onset diabetes of the youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme. Biochem J, 1995, 309( Pt 1) :167-173.
  • 10Kesavan P, Wang L, Davis E, et al. Structural instability of mutant beta-cell glucokinase:implications for the molecular pathogenesis of maturity-onset diabetes of the young (type- 2). Biochem J, 1997,322( Pt 1) :57-63.

同被引文献26

  • 1AnLk A, Catl~ G, Abac A, et al. Maturity-onset diabetes of the young (MODY) : an update [ J ]. J Pediatr Endocrinol Metab, 2015,28(3-4) :251-263. DOI: 10. 1515/jpem-2014-0384.
  • 2Chakera A J, Steele AM, Gloyn AL,et al. Recognition and man- agement of individuals with hyperglycemia because of a heterozy- gous glucokinase mutatio~ [ J ]. Diabetes Care, 2015,38 ( 7 ) : 1383-1392. DOI: 10.2337/dc14-2769.
  • 3Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucoki- nase locus on chromosome 7p to early-onset non-insulin-depend- ent diabetes mellitus [ J ]. Nature, 1992,356 ( 6365 ) : 162-164.
  • 4Stride A, Vaxillaire M, Tuomi T, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load [ J ]. Diabetologia,2002,45 ( 3 ) :427-435.
  • 5Bacon S, Schmid J, McCarthy A,et al. The clinical managementof hyperglycemia in pregnancy complicated by maturity-onset dia- betes of the young [ J ]. Am J Obstet Gynecol, 2015,213 (2) : 236. el-e7. DOI: 10. 1016/j. ajog. 2015.04. 037.
  • 6Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy[ J]. Best Pratt Res Clin Endocrinol Metab,20/0,24 (4) :6054515. DOI : 10. 1016/j. beem. 2010.05. 008.
  • 7Steele AM, Shields BM, Wensley KJ,et al. Prevalence of vascu- ~ar complications among patients with glueokinase mutations and prolonged, mild hyperglycemia [ J 3. JAMA, 2014,311 ( 3 ) : 279- 286. DOI: 10. 1001/jama. 2013. 283980.
  • 8Pruhova S, Dusatkova P, Kraml PJ,et al. Chronic mild hypergly- cemia in GCK-MODY patients does not increase carotid intima- media thickness[ J]. Int J Endocrinol,2013 ,2013 :718254. DOI: 10.1155/2013/718254.
  • 9Sp~gel P, Ekholm E, Tuomi T, et al. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucoki- nase gene ( MODY2 ) [ J 1. Diabetes, 2013,62 ( 2 ) : 6534561. DOI : 10. 2337/db12-0827.
  • 10Ellard S, Bellannr-Chantelot C, Hattersley AT,et al. Best prac- tice guidelines for the molecular genetic diagnosis of maturity-on- set diabetes of the young [ J ]. Diabetologia, 2008,51 ( 4 ) : 546-553. DOI: 10. lO07/sO0125-OO8-O942-y.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部